Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Ltd (GLHRL) is a micro-cap Healthcare Services company valued at ₹13 crore operating in Hospitals on the NSE and BSE.

Recent price move

Global Longlife Hospital and Research Ltd last traded at ₹12.73, sharply down 5.00% on the day.

Recent developments

On 2026-09-30, promoter holding dropped by 22.86 percentage points to 0.02%, indicating a significant reduction in promoter stake. The company reported a net loss of ₹2 crore in its latest financial year, reflecting a swing from a net profit of ₹0 crore to a loss of ₹2 crore.

Financial performance

The company's business has deteriorated, with annual revenue falling 100.0% and annual net profit swinging from a profit of ₹0 crore to a loss of ₹2 crore. The latest quarter showed a narrowing loss, with the net profit loss narrowing from ₹1 crore to ₹0 crore compared to the same quarter a year earlier.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.62 times book value.

Things to watch

The company reported a net loss of ₹2 crore in its latest financial year, with return on equity at -7.2% and return on capital employed at -4.2%, indicating poor profitability. The stock is 48.1% below its 52-week high, showing a significant decline in value.

Where it stands

The company stands at a net loss of ₹2 crore, with the stock 48.1% below its 52-week high. The most significant movement was the promoter holding dropping by 22.86 percentage points to 0.02%.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.